| 1 | 陈熙勐,张皓旻,杨波,等.急性髓系白血病患者预后不良相关基因的多组学分析[J].中国实验血液学杂志,2019,27(2):331-338. | 
																													
																							| 2 | 伍振辉,张欢,吴欣平,等. 基于网络药理学及体外实验探讨青黄散抗急性髓系白血病的分子机制[J]. 中国实验方剂学杂志,2022,28(7):179-189. | 
																													
																							| 3 | POLISENO L, SALMENA L, ZHANG J, et al.. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology[J]. Nature,2010,65(1):1033-1038. | 
																													
																							| 4 | 雍嘉欣,韦权峰,刘尚辉.基于TCGA和GEO数据库的胃癌lncRNA筛选与ceRNA网络构建[J].生物技术进展,2022,12(1):149-157. | 
																													
																							| 5 | HUANG D W, SHERMAN B T, LEMPICKI R A. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists[J]. Nucl. Acids Res.,2009,37(1):1-13. | 
																													
																							| 6 | 刘蓓.急性髓系白血病的免疫治疗现状[J].兰州大学学报(医学版),2021,47(6):1-9. | 
																													
																							| 7 | 董谦,龚娜英,陈康,等.急性髓系白血病潜在关键基因表达谱的生物信息学分析[J].检验医学与临床,2021,18(13):1828-1832. | 
																													
																							| 8 | ARMENTEROS-MONTERROSO E, ZHAO L, GASPAROLI L, et al.. The AAA+ATPase RUVBL2 is essential for the oncogenic function of c-MYB in acute myeloid leukemia[J]. Leukemia, 2019,33(12):2817-2829. | 
																													
																							| 9 | HIRABAYASHI S, WLODARSKI M W, KOZYRA E, et al.. Heterogeneity of GATA2-related myeloid neoplasms[J]. Int. J. Hematol. ,2017,106(2):175-182. | 
																													
																							| 10 | 程凯.人白血病细胞中c-myb的远距离表达调控机制研究[D].上海:上海海洋大学, 2020. | 
																													
																							| 11 | 尤文挺,何龙,王洒.肝细胞癌相关差异基因及关键途径的生物信息学分析[J].中西医结合肝病杂志,2021,31(11):1022-1027. | 
																													
																							| 12 | 李莉,熊国平,颜琳,等.CCNB1在卵巢癌中的表达及意义[J].现代妇产科进展,2016,25(11):818-820+824. | 
																													
																							| 13 | 崔宇平,马洪,段晓峰,等.CCNB1基因在口腔鳞状细胞癌中的表达及意义[J].实用口腔医学杂志,2019,35(3):395-397. | 
																													
																							| 14 | 金鹏,冯虎,刘倩倩,等.早期非小细胞肺癌高复发风险相关基因的生物信息学分析[J].中国生物制品学杂志,2018,31(1):35-40. | 
																													
																							| 15 | TOLEDO C M, DING Y, HOELLERBAUER P, et al.. Genome-wide CRISPR-Cas9 screens reveal loss of redundancy between PKMYT1 and WEE1 in glioblastoma stem-like cells[J]. Cell Rep., 2015,13(11):2425-2439. | 
																													
																							| 16 | LIU L, WU J, WANG S, et al.. PKMYT1 promoted the growth and motility of hepatocellular carcinoma cells by activating beta-catenin/ TCF signaling[J]. Exp. Cell Res., 2017,358(2):209-216. | 
																													
																							| 17 | JEONG D, KIM H, KIM D, et al.. Protein kinase, membrane associated tyrosine/threonine 1 is associated with the progression of colorectal cancer[J]. Oncol. Rep., 2018,39(6):2829-2836. | 
																													
																							| 18 | WANG X M, LI Q Y, REN L L, et al.. Effects of MCRS1 on proliferation, migration, invasion, and epithelial mesenchymal transition of gastric cancer cells by interacting with Pkmyt1 protein kinase[J]. Cell Signal., 2019,59:171-181. | 
																													
																							| 19 | 王莉,董陆佳,刘广贤,等. GATA2在白血病患者中的表达及其意义[J].中华血液学杂志,2001(1):26-28. | 
																													
																							| 20 | SANTO L, SIU K T, RAJE N. Targeting cyclin-dependent kinasesand cell cycle progression in human cancers[J]. Semin Oncol., 2015,42(6):788-800. | 
																													
																							| 21 | LI Q, WANG S G, WU Z Y,et al.. DDX11-AS1 exacerbates bladder cancer progression by enhancing CDK6 expression via suppressing miR-499b-5p[J]. Biomed. Pharm.,2020,127(C):110-164. | 
																													
																							| 22 | HE Z Y, DANG J, SONG A L,et al.. NEAT1 promotes colon cancer progression through sponging miR-495-3p and activating CDK6 in vitro and in vivo[J]. J. RNA Cell. Physiol.,2019,234(11): 19582-19591. | 
																													
																							| 23 | DALL' A A, SONEGO M, PELLIZZARI I, et al.. CDK6 protects epithelial ovarian cancer from platinum-induced death via FOXO3 regulation[J]. EMBO Mol. Med.,2017,9(10) :1415-1433. | 
																													
																							| 24 | AGGER K, MIYAGI S, PEDERSEN M T, et al.. Jmjd2/Kdm4 demethylases are required for expression of Il3ra and survival of acute myeloid leukemia cells[J]. Genes Dev., 2016,30(11):1278-1288. | 
																													
																							| 25 | TESTA U, PELOSI E, FRANKEL A. CD 123 is a membrane biomarker and a therapeutic target in hematologic malignancies[J/OL]. Biomark Res., 2014,2(1):4[2022-4-20]. . | 
																													
																							| 26 | TESTA U, RICCIONI R, MILITI S, et al.. Elevated expression of IL-3Ralpha in acute myelogenous leukemia is associated with enhanced blast proliferation, increased cellularity, and poor prognosis[J]. Blood, 2002,100(8):2980-2988. | 
																													
																							| 27 | BROUGHTON S E, DHAGAT U, HERCUS T R, et al.. The GM-CSF/IL-3/IL-5 cytokine receptor family: from ligand recognition to initiation of signaling[J]. Immunol. Rev., 2012,250(1):277-302. |